ZCCHC14 inhibitors are a class of chemical compounds specifically designed to target zinc finger CCHC-type containing protein 14 (ZCCHC14), a protein involved in RNA metabolism, including RNA processing, stabilization, and possibly degradation. ZCCHC14, like other proteins in the CCHC family, contains zinc finger motifs that allow it to bind RNA and mediate interactions with other proteins involved in RNA regulatory pathways. The CCHC-type zinc finger domains in ZCCHC14 are dependent on zinc ions for structural stability, which enables the protein to recognize and interact with specific RNA sequences. ZCCHC14 is implicated in controlling the fate of various RNA molecules within the cell, influencing their maturation, transport, or decay. Inhibitors of ZCCHC14 function by disrupting its RNA-binding capability or by interfering with its ability to form functional complexes with other proteins, leading to changes in RNA processing and gene expression regulation.
The mechanisms by which ZCCHC14 inhibitors exert their effects depend on the specific mode of action of the compounds. One approach involves the disruption of the zinc finger motifs, either by chelating the zinc ions that are essential for maintaining the protein's structural integrity or by directly binding to the RNA-binding regions of ZCCHC14. This inhibition prevents the protein from effectively interacting with its RNA targets, thereby impairing its role in regulating RNA metabolism. Alternatively, some inhibitors may act by blocking critical protein-protein interactions required for ZCCHC14 to perform its regulatory functions within larger RNA-protein complexes. By preventing these interactions, the inhibitors can disrupt RNA processing pathways controlled by ZCCHC14, leading to altered RNA stability and turnover. Research into ZCCHC14 inhibitors offers valuable insights into the intricate processes of RNA regulation and how RNA-binding proteins like ZCCHC14 contribute to maintaining cellular function and gene expression homeostasis.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with DNA-dependent RNA polymerase by preventing the elongation step in RNA synthesis, thus potentially reducing the transcription of ZCCHC14. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II and III, decreasing overall mRNA synthesis, including potentially that of ZCCHC14. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits RNA polymerase II, halting the transcription of mRNA, which could decrease the levels of ZCCHC14. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Inhibits exportin 1 (CRM1), leading to nuclear accumulation of RNA-binding proteins, which can alter the localization and function of ZCCHC14. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that can lead to increased levels of proteins, including possibly misfolded or dysfunctional ZCCHC14 due to impaired degradation. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis by interfering with ribosomal translocation, which may lead to reduced ZCCHC14 levels due to lack of new synthesis. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Causes premature chain termination during translation, which could result in decreased levels of functional ZCCHC14. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Inhibits peptide bond formation by binding to the 60S ribosomal subunit, which can decrease ZCCHC14 protein synthesis. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
Inhibits the initial elongation step of protein synthesis, potentially reducing ZCCHC14 levels. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Blocks N-linked glycosylation, which can affect the folding and stability of glycoproteins, potentially influencing ZCCHC14 if it is glycosylated. | ||||||